Erik Björk

3.0k total citations
57 papers, 2.4k citations indexed

About

Erik Björk is a scholar working on Surgery, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Erik Björk has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 20 papers in Pharmaceutical Science and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Erik Björk's work include Diabetes and associated disorders (18 papers), Pancreatic function and diabetes (18 papers) and Advanced Drug Delivery Systems (17 papers). Erik Björk is often cited by papers focused on Diabetes and associated disorders (18 papers), Pancreatic function and diabetes (18 papers) and Advanced Drug Delivery Systems (17 papers). Erik Björk collaborates with scholars based in Sweden, United States and India. Erik Björk's co-authors include Peter Edman, Maria Dahlin, F. Anders Karlsson, Per Artursson, Johan Gråsjö, Olle Kämpe, Ola Camber, Per Artursson, Christian Berne and Katarina Edsman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Advanced Drug Delivery Reviews.

In The Last Decade

Erik Björk

57 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Erik Björk 986 713 702 682 531 57 2.4k
Armin Mooranian 518 0.5× 555 0.8× 1.2k 1.7× 461 0.7× 469 0.9× 115 2.8k
F.W.H.M. Merkus 1.4k 1.5× 204 0.3× 223 0.3× 125 0.2× 846 1.6× 78 3.1k
Miyako Tanaka 280 0.3× 321 0.5× 348 0.5× 127 0.2× 739 1.4× 62 2.6k
V. Kolb‐Bachofen 86 0.1× 398 0.6× 560 0.8× 399 0.6× 746 1.4× 39 2.5k
Ralph W. Stevenson 58 0.1× 734 1.0× 814 1.2× 241 0.4× 1.3k 2.4× 82 2.7k
Thierry Abribat 91 0.1× 512 0.7× 306 0.4× 212 0.3× 334 0.6× 50 2.0k
Jane E. Shaw 846 0.9× 84 0.1× 119 0.2× 131 0.2× 503 0.9× 43 2.1k
Dennis J. Pillion 265 0.3× 140 0.2× 158 0.2× 42 0.1× 491 0.9× 60 1.4k
Junko Nishida 80 0.1× 249 0.3× 288 0.4× 146 0.2× 654 1.2× 39 2.4k
Miwon Son 175 0.2× 106 0.1× 199 0.3× 54 0.1× 448 0.8× 78 1.7k

Countries citing papers authored by Erik Björk

Since Specialization
Citations

This map shows the geographic impact of Erik Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Björk more than expected).

Fields of papers citing papers by Erik Björk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Björk. The network helps show where Erik Björk may publish in the future.

Co-authorship network of co-authors of Erik Björk

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Björk. A scholar is included among the top collaborators of Erik Björk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Björk. Erik Björk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schölin, Anna, L. Nyström, Hans J. Arnqvist, et al.. (2010). Proinsulin/C‐peptide ratio, glucagon and remission in new‐onset Type 1 diabetes mellitus in young adults. Diabetic Medicine. 28(2). 156–161. 33 indexed citations
2.
Björk, Erik, et al.. (2007). Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 67(2). 370–376. 19 indexed citations
3.
Westin, Ulla, Emma Boström, Johan Gråsjö, Margareta Hammarlund‐Udenaes, & Erik Björk. (2006). Direct Nose-to-Brain Transfer of Morphine After Nasal Administration to Rats. Pharmaceutical Research. 23(3). 565–572. 64 indexed citations
4.
Björk, Erik, et al.. (2005). Blood glucose in acute stroke, different therapeutic targets for diabetic and non-diabetic patients?. Acta Neurologica Scandinavica. 112(2). 81–87. 33 indexed citations
5.
Westin, Ulla, Elena Piras, Ulrika Bergström, et al.. (2005). Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents. European Journal of Pharmaceutical Sciences. 24(5). 565–573. 74 indexed citations
6.
Schölin, Anna, Carina Törn, L. Nyström, et al.. (2004). Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes. Diabetic Medicine. 21(5). 447–455. 32 indexed citations
7.
Schölin, Anna, Henrik Borg, Hans J. Arnqvist, et al.. (2004). Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in Sweden. Journal of Internal Medicine. 255(3). 384–391. 43 indexed citations
8.
Roomans, Godfried M., et al.. (2003). Uptake of Ovalbumin-conjugated Starch Microparticles by Pig Respiratory Nasal MucosaIn Vitro. Journal of drug targeting. 11(1). 75–82. 18 indexed citations
9.
Borg, Håkan, H. J. Arnqvist, Erik Björk, et al.. (2002). Islet antibodies at diagnosis versus beta-cell function eight years later in young adult patients with diabetes.. Diabetologia. 45. 476. 2 indexed citations
10.
Pundziūtė-Lyckå, Austė, Gisela Dahlquist, L. Nyström, et al.. (2002). The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0–34 years group in Sweden 1983 to 1998. Diabetologia. 45(6). 783–791. 172 indexed citations
11.
Jansson, Birgitta & Erik Björk. (2002). Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran. Journal of drug targeting. 10(5). 379–386. 58 indexed citations
12.
Paulsson, Mattias, et al.. (2002). Evaluation of drug release from gels on pig nasal mucosa in a horizontal Ussing chamber. Journal of Controlled Release. 83(3). 377–388. 23 indexed citations
13.
Dahlin, Maria, et al.. (2001). Levels of dopamine in blood and brain following nasal administration to rats. European Journal of Pharmaceutical Sciences. 14(1). 75–80. 78 indexed citations
14.
Dahlin, Maria & Erik Björk. (2001). Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer's disease to rats. International Journal of Pharmaceutics. 212(2). 267–274. 24 indexed citations
15.
Dahlin, Maria, et al.. (2000). Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice. Pharmaceutical Research. 17(6). 737–742. 86 indexed citations
16.
Dahlin, Maria & Erik Björk. (2000). Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats. International Journal of Pharmaceutics. 195(1-2). 197–205. 36 indexed citations
17.
Björk, Erik, et al.. (1999). Nasal drug delivery – evaluation of an in vitro model using porcine nasal mucosa. European Journal of Pharmaceutical Sciences. 7(3). 197–206. 60 indexed citations
18.
Schölin, Anna, Christian Berne, E. Schvarcz, F. Anders Karlsson, & Erik Björk. (1999). Factors predicting clinical remission in adult patients with type 1 diabetes. Journal of Internal Medicine. 245(2). 155–162. 46 indexed citations
19.
Björk, Erik, et al.. (1995). Starch Microspheres Induce Pulsatile Delivery of Drugs and Peptides Across the Epithelial Barrier by Reversible Separation of the Tight Junctions. Journal of drug targeting. 2(6). 501–507. 56 indexed citations
20.
Björk, Erik, Olle Kämpe, A. Andersson, & F. Anders Karlsson. (1992). Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia. 35(5). 490–493. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Armin Mooranian Breakdown of academic impact, for papers by F.W.H.M. Merkus Breakdown of academic impact, for papers by Miyako Tanaka Breakdown of academic impact, for papers by V. Kolb‐Bachofen Breakdown of academic impact, for papers by Ralph W. Stevenson Breakdown of academic impact, for papers by Thierry Abribat Breakdown of academic impact, for papers by Jane E. Shaw Breakdown of academic impact, for papers by Dennis J. Pillion Breakdown of academic impact, for papers by Junko Nishida Breakdown of academic impact, for papers by Miwon Son
Rankless by CCL
2026